Effects of dorzolamide/timolol fixed combination on retrobulbar hemodynamics in pseudoexfoliative glaucoma  by Eliacik, Mustafa et al.
Kaohsiung Journal of Medical Sciences (2016) 32, 38e43Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLEEffects of dorzolamide/timolol fixed combination
on retrobulbar hemodynamics in
pseudoexfoliative glaucoma
Mustafa Eliacik a,*, Sevil Karaman Erdur a, Inci Baltepe Altıok b,
Gokhan Gulkilik a, Cemile Anil Aslan a, Faruk Kaya aa Department of Ophthalmology, School of Medicine, Istanbul Medipol University, Istanbul,
Turkey
b Department of Radiology, Istanbul Medipol University, School of Medicine, TurkeyReceived 12 August 2015; accepted 18 December 2015
Available online 23 January 2016KEYWORDS
Color Doppler
imaging;
Dorzolamide/timolol;
Glaucoma;
Pseudoexfoliation;
Retrobulbar ocular
blood flowConflicts of interest: All authors d
* Corresponding author. Istanbul Med
Kadikoy, Istanbul, Turkey.
E-mail address: drmustafaeliacik@
http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2016, Kaohsiu
CC BY-NC-ND license (http://creativeAbstract In our study we aimed to evaluate the short-term effects of dorzolamide/timolol on
ocular perfusion pressure and retrobulbar blood flow in patients with pseudoexfoliative glau-
coma (PXG). This prospective observational cross-sectional study enrolled 22 eyes of 22 newly-
diagnosed patients with PXG in a single center. All of the patients received a fixed combination
of dorzolamide/timolol. Besides routine ophthalmologic examination, the retrobulbar hemo-
dynamic parameters in the ophthalmic artery, central retinal artery, and short posterior ciliary
arteries were measured in all participants at baseline and the 3rd month using color Doppler
imaging. The mean intraocular pressure (IOP) was 22.3  2.1 mmHg at baseline and reduced
to 17.4  2.3 mmHg at the 3rd month (p < 0.05). None of the retrobulbar parameters, except
peak systolic velocity and resistive index in temporal short posterior ciliary arteries, changed
significantly on therapy with dorzolamide/timolol fixed combination when the results were
analyzed at Month 3. The drug significantly decreased the peak systolic velocity (p Z 0.044)
and reduced the resistive index in 0.04 units, 95% confidence interval 0.03e0.05,
(p < 0.001) in the temporal short posterior ciliary arteries. This study reports that the retro-
bulbar hemodynamics might be affected less than expected by dorzolamide/timolol fixed com-
bination in patients with PXG although the reduction of IOP was statistically significant.
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Pseudoexfoliation syndrome is one of the most commonly
identifiable causes of glaucoma overall [1]. Secondary
chronic open-angle glaucoma as a result of blockage of the
outflow channels by pseudoexfoliation material has been
reported between 20% and 25% of all glaucomas [2]. Some
previous studies have shown the accumulation of pseu-
doexfoliation material in the wall of central retinal artery,
short posterior ciliary arteries, and vortex veins. A possible
role in disturbance in the blood flow has been reported in
patients with pseudoexfoliation syndrome.
The major role of carbonic anhydrase inhibitors (CAIs) on
intraocular pressure (IOP) is reducing aqueous humor
secretion by inhibition of carbonic anhydrase in the ciliary
processes. In addition to IOP lowering effect of this group
drugs, dorzolamide and brinzolamide also increase the
retrobulbar ocular blood flow by arterial vasodilation
[3e6]. Several studies, using different methods, indicated
that dorzolamide reduced retrobulbar ocular blood flow
[7e9].
The purpose of this study was to compare the effects of
dorzolamide/timolol fixed combination on retrobulbar
ocular blood flow parameters in patients with pseudoexfo-
liative glaucoma (PXG) using color Doppler imaging.
Materials and methods
This prospective observational cross-sectional study
included 22 eyes of 22 patients (12 females, 10 males) with
PXG, who are newly diagnosed at Medipol University School
of Medicine, Department of Ophthalmology, Istanbul.
The inclusion criteria were having a white pupillary ruff
and the presence of a manifest pseudoexfoliation deposi-
tion pattern in the anterior lens capsule, intraocular pres-
sure (IOP) > 21 mmHg with a typical glaucomatous disk, an
open chamber angle, and characteristic glaucomatous vi-
sual field loss.
Exclusion criteria were eyes lacking clear corneas or
those having posterior segment pathologies, previous
intraocular surgery, ocular trauma or other intraocular pa-
thology, or who were unable to understand the study or
communicate. The study protocol was approved by the
Ethics Committee of Medipol University. The tenets of the
Declaration of Helsinki were followed and all patients
provided informed consent prior to enrollment.
All patients underwent routine ophthalmic examinations
including visual acuity, Goldmann tonometry, slit-lamp bio-
microscopy, and fundoscopy. Color Doppler imaging mea-
surementswere performed by an experienced radiologistwith
a 7.5-MHz linear transducer using acoustic gel at baseline and
3rd month using Color Doppler imaging (LOGIQ P6; GE Health-
care, Milwaukee andWisconsin, USA). For the measurements,
patients were in the supine position with their eyes closed
while looking straight ahead. During the examination minimal
pressure was applied on the eye so as not to cause any alter-
ations in retrobulbar blood flow measurements.
Ophthalmic artery blood flow parameters were obtained
w25 mm behind the globe, from the point where the artery
crossed the optic nerve. The central retinal artery and vein
were measurablew10 mm behind the retrolaminar portionof the optic nerve. The nasal and temporal short posterior
ciliary arteries were examined w10e20 mm behind the
globe just before they branched. Values for each artery,
peak systolic velocity, and end diastolic velocity were ob-
tained from the color Doppler signals. The resistive index
was calculated by Pourcelot’s formula [Resistive Index Z
(Peak Systolic Velocity  End Diastolic Velocity)/Peak Sys-
tolic Velocity]. Mean central retinal vein velocity was
calculated from the color Doppler signals.
All statistical analyzes were performed using SPSS
version 20 (SPSS Inc., Chicago, IL, USA). A Kolmogor-
oveSmirnov test was used to test for normality between
samples, followed by a Levene test to assess equal vari-
ances. Wilcoxon test was used to compare the variables. All
p values were two-sided and were considered statistically
significant when p < 0.05.
Results
The mean age of patients was 63.15  3.82 years (range,
52e68 years old) (12 females, 10 males). The mean IOP was
22.3  2.1 mmHg at baseline and 17.4  2.3 mmHg at the
3rd month. There was a significant decrease in IOP
(p < 0.05). Retrobulbar hemodynamic variables at baseline
and 3 months are given in Table 1. The mean blood flow
velocities and resistance indices values, except peak sys-
tolic velocity and resistive index in temporal short posterior
ciliary arteries, measured at baseline were not different
from the values after 3 months of treatment with dorzo-
lamide/timolol in patients with PXG (p > 0.05; Figures 1
and 2). The drug significantly reduced the resistive index
in the temporal short posterior ciliary arteries from 0.60
(0.02) to 0.54 (0.02) and peak systolic velocity from
3  6.8 cm/s to 2.7  7 cm/s (p Z 0.001 and p Z 0.044,
respectively).
Discussion
Pseudoexfoliation syndrome, an important cause of glau-
coma, presents with an abnormal fibrillar extracellular
material production and accumulation in anterior segment
tissues pathologically [10]. Recent studies have described
various intraocular complications associated with pseu-
doexfoliation syndrome [2,10e13]. According to electron
microscopic investigations in autopsy specimens, pseu-
doexfoliation fibrils are observed not only in the eye, but
also in the heart, lung, liver, gall bladder, and cerebral
meninges [10]. Some studies suggested that, pseudoexfo-
liation syndrome seemed to extensively involve the
vascular structures, causing a higher degree of decrease in
orbital blood flow and circulation which presumably leads
to glaucomatous damage faster than in primary open angle
glaucoma patients without pseudoexfoliation [14]. In
addition hemodynamic parameters in the retrobulbar ves-
sels, especially in the central retinal artery and short pos-
terior ciliary arteries which are the primary blood fund of
the superficial nerve fiber layer, prelaminar, and laminar
regions, are significantly lower in patients with PXG than in
those healthy participants [14]. PXG has mostly worse
outcomes compared with primary open angle glaucoma
with high IOP levels, significant differences in pressure
Table 1 Retrobulbar hemodynamic variables at baseline and 3 months after dorzolamid/timolol administration in patients
with pseudoexfoliative glaucoma.
Variables Baseline 3rd month p *
Mean  SD MineMax Mean  SD MineMax
Ophthalmic artery PSV 12.75  5.2 5.4e26.7 12.05  5.34 4.3e26.1 0.251
EDV 47.61  19.97 23.9e101.7 44.73  14.97 20.3e85.3 0.352
RI 0.72  0.89 0.42e0.85 0.71  0.08 0.49e0.84 0.153
Central artery PSV 5.25  1.56 2.30e7.40 5.27  1.99 1.6e9 0.909
EDV 19.43  6.97 8.20e38.3 18.31  5.45 7.1e35.4 0.254
RI 0.71  0.06 0.63e0.88 0.70  0.07 0.61e0.85 0.696
Nasal posterior ciliary artery PSV 4.57  0.71 3e5.8 4.59  1.06 3.2e6.8 0.653
EDV 15.6  3.37 9.5e19.7 15.15  2.96 8.4e20.3 0.355
RI 0.69  0.05 0.57e0.77 0.69  0.25 0.56e0.79 0.856
Temporal posterior ciliary artery PSV 3  6.8 4.75e0.95 2.7  7 5.32e1.05 0.044
EDV 8.4  22 15.78e3.56 8.2  22 15.32e3.09 0.897
RI 0.61  0.77 0.69e0.05 0.57  0.76 0.64e0.05 0.001
EDV Z end diastolic velocity (cm/s); PSV Z peak systolic velocity (cm/s); RI Z resistivity index; SD Z standard deviation.
* Wilcoxon test.
40 M. Eliacik et al.between two eyes and also diurnal fluctuations. On the
basis of these observations, it must be emphasized that
modern antiglaucoma therapies should aim to affect not
only intraocular pressure, but also other factors such as
ocular blood flow. Although the effects of topical CAI drugs
on ocular blood flow velocities were measured and the
evidence obtained from these studies suggests that CAI
agents increase the ocular blood flow velocities, the effect
of these types of drugs was not investigated on primary
open angle glaucoma patients with pseudoexfoliation
[3e6,15]. The resistive index lowering effect of dorzola-
mide can be related to its vasodilator effect on ophthalmicFigure 1. Peak systolic velocity, end diastolic velocity, and re
ophthalmic artery (C, D) in patients with pseudoexfoliative glaucoand retinal vessels. Accumulation of abnormal fibrillar
extracellular material in pseudoexfoliation possibly causes
some changes in the vessel walls.
Since Harris et al [9] reported topical dorzolamide
accelerated the blood velocity in the retinal and superficial
optic nerve head but had no effect on retrobulbar hemo-
dynamics, several studies have been conducted to achieve
a clear and distinct result regarding the relationship be-
tween topical CAI and retrobulbar blood flow [3,9,16e21].
Although dorzolamide alone is not the most potent agent to
lower IOP, compared with surgery or even with other
topical antiglaucoma medications, it has a dual action, thesistive index values of the central retinal artery (A, B) and
ma, at the two time points.
Figure 2. Peak systolic velocity, end diastolic velocity, and resistive index values of the temporal short posterior ciliary arteries
(A, B) and nasal short posterior ciliary arteries (C, D) in patients with pseudoexfoliative glaucoma, at the two time points.
PXG and retrobulbar hemodynamics 41vasodilating and IOP lowering effect. Martinez et al [22]
indicate that dorzolamide/timolol fixed combination has
been shown to be effective and generally well tolerated.
Their study was carried out on patients diagnosed as having
primary open-angle glaucoma or pseudoexfoliation glau-
coma. The results of this retrospective study indicate that
dorzolamide/timolol fixed combination is effective in
reducing IOP in glaucoma patients (even though with
pseudoexfoliation) who did not respond to prostaglandin
analogs/prostamides [22]. Based on previous studies with
dorzolamide, most of the color Doppler imaging parame-
ters, except in the ophthalmic artery, have clearly
improved [9,16,17]. This is highly interesting, and it re-
mains unclear why essentially similar medications, such as
brinzolamide, demonstrates such differences in their
vasoactive pharmacological effects. Martinez et al [3] point
to differences between dorzolamide and brinzolamide in
their impact on ocular blood flow outcomes in glaucoma-
tous eyes over 5 years. According to their findings lower
diastolic blood pressure, lower mean arterial pressure,
antihypertensive medication, lower end diastolic velocity
in the ophthalmic artery and short posterior ciliary arteries,
and higher resistive index in the ophthalmic artery and
short posterior ciliary arteries lead to progression in glau-
coma. Also they showed dorzolamide/timolol fixed combi-
nation treatment reduced the risk for progression
compared with brinzolamide/timolol fixed combination
treatment half-and-half. These results are compatible with
those previously reported by Galassi et al [16], Satilmis et al
[23], and Zeitz et al [24,25]. They concluded that there is a
straight relation between reduced ocular blood flow and
visual field loss, and enhanced blood flow can influence the
visual function of glaucoma patients. By contrast to these
findings Siesky et al [26] found that brinzolamide anddorzolamide may provide an increase in retinal oxygen
saturation in patients with primary open angle glaucoma
without any influence on the retrobulbar blood supply. In
another published study Siesky et al [19] also compared the
effects of dorzolamide/timolol and brimonidine/timolol
combinations on ocular blood flow in a 1-month period and
found the same results with their previous study. Both
studies included 15 primary open angle glaucoma patients.
One of the most important limitations of these studies is
number of patients. A small number of cases cast doubts on
vasodilatator effects of dorzolamide. Yu¨ksel et al found
significant decreases in all orbital blood flow velocities, and
increases in the resistive index values in patients with PXG,
as compared with controls. In their study, patients with PXG
showed statistically significant decreases in the mean peak
systolic and end-diastolic velocities and increased mean
resistive indices in all vessels except for the ophthalmic
artery mean peak systolic velocity compared with the
control individuals. Patients with primary open angle
glaucoma, when compared with the control individuals,
showed statistically significant decreases in the mean end-
diastolic velocities and increased mean resistive indices in
all vessels measured. They also indicate that no statistically
significant differences were found in the mean blood flow
parameters between primary open angle glaucoma and
PXG. Although no significant difference in the mean blood
flow parameters was found between primary open angle
glaucoma and PXG, alterations of retrobulbar vessels might
be associated with different pathogenic mechanisms of PXG
[27,28].
In the current investigation, we examined the effects of
dorzolamide on retrobulbar blood flow in newly diagnosed
PXG patients. To the best of our knowledge, there has been
no prior published study that has reported on the ocular
42 M. Eliacik et al.blood flow effects of dorzolamide/timolol fixed combina-
tion in primary open angle glaucoma patients with
pseudoexfoliation.
A major limitation of our study is there is no control or
comparative groups such as primary open angle glaucoma
patients. Further studies including these groups would be
more informative.
Previous studies, investigating the vaso-relaxing effect
of CAI, pointed out that dorzolamide depended on its
vasodilator effect on carbonic anhydrases in the peri-
vascular tissue, involving different membrane-bound iso-
enzymes IV and XIV found in the retinal astrocytes and
Muller cell. However, we think that accumulation of pseu-
doexfoliation material in the cells such as vascular endo-
thelial cells, smooth muscle cells, and pericytes, which
regulate local microcirculation, could achieve this result in
patients with PXG.
Most of the previous studies supported the positive
effect of dorzolamide on retrobulbar hemodynamics. The
results of this study showed that the retrobulbar hemo-
dynamics might be affected less than expected by dor-
zolamide/timolol fixed combination in patients with PXG,
although the reduction of IOP was statistically signifi-
cant. This finding raises some questions regarding the
effects of pseudoexfoliation on retrobulbar vascular
structures; such as vascular endothelial cells, smooth
muscle cells, and pericytes. Further investigations with
other types of antiglaucoma drugs are needed to confirm
our results.References
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